Global Hereditary Angioedema Treatment Market Report 2021
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
At the beginning of 2020, COVID-19 disease began to spread around the world, millions of people worldwide were infected with COVID-19 disease, and major countries around the world have implemented foot prohibitions and work stoppage orders. Except for the medical supplies and life support products industries, most industries have been greatly impacted, and Hereditary Angioedema Treatment industries have also been greatly affected.
In the past few years, the Hereditary Angioedema Treatment market experienced a growth of 15, the global market size of Hereditary Angioedema Treatment reached XXX million $ in 2020, of what is about XXX million $ in 2015.
From 2015 to 2019, the growth rate of global Hereditary Angioedema Treatment market size was in the range of xxx%. At the end of 2019, COVID-19 began to erupt in China, Due to the huge decrease of global economy; we forecast the growth rate of global economy will show a decrease of about 4%, due to this reason, Hereditary Angioedema Treatment market size in 2020 will be XXX with a growth rate of xxx%. This is xxx percentage points lower than in previous years.
As of the date of the report, there have been more than 20 million confirmed cases of CVOID-19 worldwide, and the epidemic has not been effectively controlled. Therefore, we predict that the global epidemic will be basically controlled by the end of 2020 and the global Hereditary Angioedema Treatment market size will reach XXX million $ in 2025, with a CAGR of xxx% between 2020-2025.
This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.
Section 1: Free——Definition
Section (2 3): 1200 USD——Manufacturer Detail
CSL
Pharming Group
Shire plc (Takeda Pharmaceutical Company Limited)
Ionis Pharmaceuticals
Attune Pharmaceuticals
BioCryst Pharmaceuticals
KalVista Pharmaceuticals
Section 4: 900 USD——Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7): 500 USD——
Product Type Segmentation
C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
Selective Bradykinin B2 Receptor Antagonists (Firazyr)
Kallikrein Inhibitors (Kalbitor, Takhzyro)
Others (Conventional Drugs, Pipeline Drugs)
Industry Segmentation
Hospital Pharmacies
Retail Pharmacies
Others (online pharmacies, mail pharmacies)
Channel (Direct Sales, Distributor) Segmentation
Section 8: 400 USD——Trend (2020-2025)
Section 9: 300 USD——Product Type Detail
Section 10: 700 USD——Downstream Consumer
Section 11: 200 USD——Cost Structure
Section 12: 500 USD——Conclusion
Section 1 Hereditary Angioedema Treatment Product Definition
Section 2 Global Hereditary Angioedema Treatment Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Hereditary Angioedema Treatment Shipments
2.2 Global Manufacturer Hereditary Angioedema Treatment Business Revenue
2.3 Global Hereditary Angioedema Treatment Market Overview
2.4 COVID-19 Impact on Hereditary Angioedema Treatment Industry
Section 3 Manufacturer Hereditary Angioedema Treatment Business Introduction
3.1 CSL Hereditary Angioedema Treatment Business Introduction
3.1.1 CSL Hereditary Angioedema Treatment Shipments, Price, Revenue and Gross profit 2015-2020
3.1.2 CSL Hereditary Angioedema Treatment Business Distribution by Region
3.1.3 CSL Interview Record
3.1.4 CSL Hereditary Angioedema Treatment Business Profile
3.1.5 CSL Hereditary Angioedema Treatment Product Specification
3.2 Pharming Group Hereditary Angioedema Treatment Business Introduction
3.2.1 Pharming Group Hereditary Angioedema Treatment Shipments, Price, Revenue and Gross profit 2015-2020
3.2.2 Pharming Group Hereditary Angioedema Treatment Business Distribution by Region
3.2.3 Interview Record
3.2.4 Pharming Group Hereditary Angioedema Treatment Business Overview
3.2.5 Pharming Group Hereditary Angioedema Treatment Product Specification
3.3 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Business Introduction
3.3.1 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Shipments, Price, Revenue and Gross profit 2015-2020
3.3.2 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Business Distribution by Region
3.3.3 Interview Record
3.3.4 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Business Overview
3.3.5 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product Specification
3.4 Ionis Pharmaceuticals Hereditary Angioedema Treatment Business Introduction
3.5 Attune Pharmaceuticals Hereditary Angioedema Treatment Business Introduction
3.6 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Business Introduction
…
Section 4 Global Hereditary Angioedema Treatment Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Hereditary Angioedema Treatment Market Size and Price Analysis 2015-2020
4.1.2 Canada Hereditary Angioedema Treatment Market Size and Price Analysis 2015-2020
4.2 South America Country
4.2.1 South America Hereditary Angioedema Treatment Market Size and Price Analysis 2015-2020
4.3 Asia Country
4.3.1 China Hereditary Angioedema Treatment Market Size and Price Analysis 2015-2020
4.3.2 Japan Hereditary Angioedema Treatment Market Size and Price Analysis 2015-2020
4.3.3 India Hereditary Angioedema Treatment Market Size and Price Analysis 2015-2020
4.3.4 Korea Hereditary Angioedema Treatment Market Size and Price Analysis 2015-2020
4.4 Europe Country
4.4.1 Germany Hereditary Angioedema Treatment Market Size and Price Analysis 2015-2020
4.4.2 UK Hereditary Angioedema Treatment Market Size and Price Analysis 2015-2020
4.4.3 France Hereditary Angioedema Treatment Market Size and Price Analysis 2015-2020
4.4.4 Italy Hereditary Angioedema Treatment Market Size and Price Analysis 2015-2020
4.4.5 Europe Hereditary Angioedema Treatment Market Size and Price Analysis 2015-2020
4.5 Other Country and Region
4.5.1 Middle East Hereditary Angioedema Treatment Market Size and Price Analysis 2015-2020
4.5.2 Africa Hereditary Angioedema Treatment Market Size and Price Analysis 2015-2020
4.5.3 GCC Hereditary Angioedema Treatment Market Size and Price Analysis 2015-2020
4.6 Global Hereditary Angioedema Treatment Market Segmentation (Region Level) Analysis 2015-2020
4.7 Global Hereditary Angioedema Treatment Market Segmentation (Region Level) Analysis
Section 5 Global Hereditary Angioedema Treatment Market Segmentation (Product Type Level)
5.1 Global Hereditary Angioedema Treatment Market Segmentation (Product Type Level) Market Size 2015-2020
5.2 Different Hereditary Angioedema Treatment Product Type Price 2015-2020
5.3 Global Hereditary Angioedema Treatment Market Segmentation (Product Type Level) Analysis
Section 6 Global Hereditary Angioedema Treatment Market Segmentation (Industry Level)
6.1 Global Hereditary Angioedema Treatment Market Segmentation (Industry Level) Market Size 2015-2020
6.2 Different Industry Price 2015-2020
6.3 Global Hereditary Angioedema Treatment Market Segmentation (Industry Level) Analysis
Section 7 Global Hereditary Angioedema Treatment Market Segmentation (Channel Level)
7.1 Global Hereditary Angioedema Treatment Market Segmentation (Channel Level) Sales Volume and Share 2015-2020
7.2 Global Hereditary Angioedema Treatment Market Segmentation (Channel Level) Analysis
Section 8 Hereditary Angioedema Treatment Market Forecast 2020-2025
8.1 Hereditary Angioedema Treatment Segmentation Market Forecast (Region Level)
8.2 Hereditary Angioedema Treatment Segmentation Market Forecast (Product Type Level)
8.3 Hereditary Angioedema Treatment Segmentation Market Forecast (Industry Level)
8.4 Hereditary Angioedema Treatment Segmentation Market Forecast (Channel Level)
Section 9 Hereditary Angioedema Treatment Segmentation Product Type
9.1 C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Product Introduction
9.2 Selective Bradykinin B2 Receptor Antagonists (Firazyr) Product Introduction
9.3 Kallikrein Inhibitors (Kalbitor, Takhzyro) Product Introduction
9.4 Others (Conventional Drugs, Pipeline Drugs) Product Introduction
Section 10 Hereditary Angioedema Treatment Segmentation Industry
10.1 Hospital Pharmacies Clients
10.2 Retail Pharmacies Clients
10.3 Others (online pharmacies, mail pharmacies) Clients
Section 11 Hereditary Angioedema Treatment Cost of Production Analysis
11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview
Section 12 Conclusion
Chart and Figure
Figure Hereditary Angioedema Treatment Product Picture from CSL
Chart 2015-2020 Global Manufacturer Hereditary Angioedema Treatment Shipments (Units)
Chart 2015-2020 Global Manufacturer Hereditary Angioedema Treatment Shipments Share
Chart 2015-2020 Global Manufacturer Hereditary Angioedema Treatment Business Revenue (Million USD)
Chart 2015-2020 Global Manufacturer Hereditary Angioedema Treatment Business Revenue Share
Chart CSL Hereditary Angioedema Treatment Shipments, Price, Revenue and Gross profit 2015-2020
Chart CSL Hereditary Angioedema Treatment Business Distribution
Chart CSL Interview Record (Partly)
Figure CSL Hereditary Angioedema Treatment Product Picture
Chart CSL Hereditary Angioedema Treatment Business Profile
Table CSL Hereditary Angioedema Treatment Product Specification
Chart Pharming Group Hereditary Angioedema Treatment Shipments, Price, Revenue and Gross profit 2015-2020
Chart Pharming Group Hereditary Angioedema Treatment Business Distribution
Chart Pharming Group Interview Record (Partly)
Figure Pharming Group Hereditary Angioedema Treatment Product Picture
Chart Pharming Group Hereditary Angioedema Treatment Business Overview
Table Pharming Group Hereditary Angioedema Treatment Product Specification
Chart Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Shipments, Price, Revenue and Gross profit 2015-2020
Chart Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Business Distribution
Chart Shire plc (Takeda Pharmaceutical Company Limited) Interview Record (Partly)
Figure Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product Picture
Chart Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Business Overview
Table Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product Specification
3.4 Ionis Pharmaceuticals Hereditary Angioedema Treatment Business Introduction
…
Chart United States Hereditary Angioedema Treatment Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart United States Hereditary Angioedema Treatment Sales Price ($/Unit) 2015-2020
Chart Canada Hereditary Angioedema Treatment Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Canada Hereditary Angioedema Treatment Sales Price ($/Unit) 2015-2020
Chart South America Hereditary Angioedema Treatment Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart South America Hereditary Angioedema Treatment Sales Price ($/Unit) 2015-2020
Chart China Hereditary Angioedema Treatment Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart China Hereditary Angioedema Treatment Sales Price ($/Unit) 2015-2020
Chart Japan Hereditary Angioedema Treatment Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Japan Hereditary Angioedema Treatment Sales Price ($/Unit) 2015-2020
Chart India Hereditary Angioedema Treatment Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart India Hereditary Angioedema Treatment Sales Price ($/Unit) 2015-2020
Chart Korea Hereditary Angioedema Treatment Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Korea Hereditary Angioedema Treatment Sales Price ($/Unit) 2015-2020
Chart Germany Hereditary Angioedema Treatment Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Germany Hereditary Angioedema Treatment Sales Price ($/Unit) 2015-2020
Chart UK Hereditary Angioedema Treatment Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart UK Hereditary Angioedema Treatment Sales Price ($/Unit) 2015-2020
Chart France Hereditary Angioedema Treatment Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart France Hereditary Angioedema Treatment Sales Price ($/Unit) 2015-2020
Chart Italy Hereditary Angioedema Treatment Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Italy Hereditary Angioedema Treatment Sales Price ($/Unit) 2015-2020
Chart Europe Hereditary Angioedema Treatment Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Europe Hereditary Angioedema Treatment Sales Price ($/Unit) 2015-2020
Chart Middle East Hereditary Angioedema Treatment Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Middle East Hereditary Angioedema Treatment Sales Price ($/Unit) 2015-2020
Chart Africa Hereditary Angioedema Treatment Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Africa Hereditary Angioedema Treatment Sales Price ($/Unit) 2015-2020
Chart GCC Hereditary Angioedema Treatment Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart GCC Hereditary Angioedema Treatment Sales Price ($/Unit) 2015-2020
Chart Global Hereditary Angioedema Treatment Market Segmentation (Region Level) Sales Volume 2015-2020
Chart Global Hereditary Angioedema Treatment Market Segmentation (Region Level) Market size 2015-2020
Chart Hereditary Angioedema Treatment Market Segmentation (Product Type Level) Volume (Units) 2015-2020
Chart Hereditary Angioedema Treatment Market Segmentation (Product Type Level) Market Size (Million $) 2015-2020
Chart Different Hereditary Angioedema Treatment Product Type Price ($/Unit) 2015-2020
Chart Hereditary Angioedema Treatment Market Segmentation (Industry Level) Market Size (Volume) 2015-2020
Chart Hereditary Angioedema Treatment Market Segmentation (Industry Level) Market Size (Share) 2015-2020
Chart Hereditary Angioedema Treatment Market Segmentation (Industry Level) Market Size (Value) 2015-2020
Chart Global Hereditary Angioedema Treatment Market Segmentation (Channel Level) Sales Volume (Units) 2015-2020
Chart Global Hereditary Angioedema Treatment Market Segmentation (Channel Level) Share 2015-2020
Chart Hereditary Angioedema Treatment Segmentation Market Forecast (Region Level) 2020-2025
Chart Hereditary Angioedema Treatment Segmentation Market Forecast (Product Type Level) 2020-2025
Chart Hereditary Angioedema Treatment Segmentation Market Forecast (Industry Level) 2020-2025
Chart Hereditary Angioedema Treatment Segmentation Market Forecast (Channel Level) 2020-2025
Chart C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Product Figure
Chart C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Product Advantage and Disadvantage Comparison
Chart Selective Bradykinin B2 Receptor Antagonists (Firazyr) Product Figure
Chart Selective Bradykinin B2 Receptor Antagonists (Firazyr) Product Advantage and Disadvantage Comparison
Chart Kallikrein Inhibitors (Kalbitor, Takhzyro) Product Figure
Chart Kallikrein Inhibitors (Kalbitor, Takhzyro) Product Advantage and Disadvantage Comparison
Chart Others (Conventional Drugs, Pipeline Drugs) Product Figure
Chart Others (Conventional Drugs, Pipeline Drugs) Product Advantage and Disadvantage Comparison
Chart Hospital Pharmacies Clients
Chart Retail Pharmacies Clients
Chart Others (online pharmacies, mail pharmacies) Clients
Research Methodology:
Hereditary Angioedema Treatment Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|